150 related articles for article (PubMed ID: 21217070)
1. Myocardial transfection with naked DNA plasmid encoding hepatocyte growth factor prevents the progression of heart failure in dogs.
Rastogi S; Guerrero M; Wang M; Ilsar I; Sabbah MS; Gupta RC; Sabbah HN
Am J Physiol Heart Circ Physiol; 2011 Apr; 300(4):H1501-9. PubMed ID: 21217070
[TBL] [Abstract][Full Text] [Related]
2. Chronic monotherapy with rosuvastatin prevents progressive left ventricular dysfunction and remodeling in dogs with heart failure.
Zacà V; Rastogi S; Imai M; Wang M; Sharov VG; Jiang A; Goldstein S; Sabbah HN
J Am Coll Cardiol; 2007 Aug; 50(6):551-7. PubMed ID: 17678740
[TBL] [Abstract][Full Text] [Related]
3. Therapy with cardiac contractility modulation electrical signals improves left ventricular function and remodeling in dogs with chronic heart failure.
Imai M; Rastogi S; Gupta RC; Mishra S; Sharov VG; Stanley WC; Mika Y; Rousso B; Burkhoff D; Ben-Haim S; Sabbah HN
J Am Coll Cardiol; 2007 May; 49(21):2120-8. PubMed ID: 17531662
[TBL] [Abstract][Full Text] [Related]
4. Ranolazine combined with enalapril or metoprolol prevents progressive LV dysfunction and remodeling in dogs with moderate heart failure.
Rastogi S; Sharov VG; Mishra S; Gupta RC; Blackburn B; Belardinelli L; Stanley WC; Sabbah HN
Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H2149-55. PubMed ID: 18820026
[TBL] [Abstract][Full Text] [Related]
5. Effects of long-term therapy with bosentan on the progression of left ventricular dysfunction and remodeling in dogs with heart failure.
Mishima T; Tanimura M; Suzuki G; Todor A; Sharov VG; Goldstein S; Sabbah HN
J Am Coll Cardiol; 2000 Jan; 35(1):222-9. PubMed ID: 10636284
[TBL] [Abstract][Full Text] [Related]
6. Reduced sarcoplasmic reticulum Ca(2+)-uptake and expression of phospholamban in left ventricular myocardium of dogs with heart failure.
Gupta RC; Mishra S; Mishima T; Goldstein S; Sabbah HN
J Mol Cell Cardiol; 1999 Jul; 31(7):1381-9. PubMed ID: 10403755
[TBL] [Abstract][Full Text] [Related]
7. Darbepoetin-alpha prevents progressive left ventricular dysfunction and remodeling in nonanemic dogs with heart failure.
Rastogi S; Imai M; Sharov VG; Mishra S; Sabbah HN
Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2475-82. PubMed ID: 18952719
[TBL] [Abstract][Full Text] [Related]
8. Postinfarction treatment with an adenoviral vector expressing hepatocyte growth factor relieves chronic left ventricular remodeling and dysfunction in mice.
Li Y; Takemura G; Kosai K; Yuge K; Nagano S; Esaki M; Goto K; Takahashi T; Hayakawa K; Koda M; Kawase Y; Maruyama R; Okada H; Minatoguchi S; Mizuguchi H; Fujiwara T; Fujiwara H
Circulation; 2003 May; 107(19):2499-506. PubMed ID: 12695295
[TBL] [Abstract][Full Text] [Related]
9. Effects of recombinant adenovirus hepatocyte growth factor gene on myocardial remodeling in spontaneously hypertensive rats.
Hu ZP; Bao Y; Chen DN; Cheng Y; Song B; Liu M; Li D; Wang BN
J Cardiovasc Pharmacol Ther; 2013 Sep; 18(5):476-80. PubMed ID: 23739651
[TBL] [Abstract][Full Text] [Related]
10. Selective matrix metalloproteinase inhibition attenuates progression of left ventricular dysfunction and remodeling in dogs with chronic heart failure.
Morita H; Khanal S; Rastogi S; Suzuki G; Imai M; Todor A; Sharov VG; Goldstein S; O'Neill TP; Sabbah HN
Am J Physiol Heart Circ Physiol; 2006 Jun; 290(6):H2522-7. PubMed ID: 16428338
[TBL] [Abstract][Full Text] [Related]
11. Gene transfection with human hepatocyte growth factor complementary DNA plasmids attenuates cardiac remodeling after acute myocardial infarction in goat hearts implanted with ventricular assist devices.
Shirakawa Y; Sawa Y; Takewa Y; Tatsumi E; Kaneda Y; Taenaka Y; Matsuda H
J Thorac Cardiovasc Surg; 2005 Sep; 130(3):624-32. PubMed ID: 16153905
[TBL] [Abstract][Full Text] [Related]
12. A novel method of augmenting gene expression and angiogenesis in the normal and ischemic canine myocardium.
Yuan QY; Zhu ZW; Wang Z; Wang XM; Li XS; Huang J; Si LY
Heart Vessels; 2012 May; 27(3):316-26. PubMed ID: 21688013
[TBL] [Abstract][Full Text] [Related]
13. Effects of AT1-receptor blockade on progression of left ventricular dysfunction in dogs with heart failure.
Tanimura M; Sharov VG; Shimoyama H; Mishima T; Levine TB; Goldstein S; Sabbah HN
Am J Physiol; 1999 Apr; 276(4):H1385-92. PubMed ID: 10199866
[TBL] [Abstract][Full Text] [Related]
14. Atenolol is inferior to metoprolol in improving left ventricular function and preventing ventricular remodeling in dogs with heart failure.
Zacà V; Rastogi S; Mishra S; Wang M; Sharov VG; Gupta RC; Goldstein S; Sabbah HN
Cardiology; 2009; 112(4):294-302. PubMed ID: 18832825
[TBL] [Abstract][Full Text] [Related]
15. Augmentation of left ventricular wall thickness with alginate hydrogel implants improves left ventricular function and prevents progressive remodeling in dogs with chronic heart failure.
Sabbah HN; Wang M; Gupta RC; Rastogi S; Ilsar I; Sabbah MS; Kohli S; Helgerson S; Lee RJ
JACC Heart Fail; 2013 Jun; 1(3):252-8. PubMed ID: 23998003
[TBL] [Abstract][Full Text] [Related]
16. Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failure.
Suzuki G; Morita H; Mishima T; Sharov VG; Todor A; Tanhehco EJ; Rudolph AE; McMahon EG; Goldstein S; Sabbah HN
Circulation; 2002 Dec; 106(23):2967-72. PubMed ID: 12460880
[TBL] [Abstract][Full Text] [Related]
17. Treatment of acute myocardial infarction by hepatocyte growth factor gene transfer: the first demonstration of myocardial transfer of a "functional" gene using ultrasonic microbubble destruction.
Kondo I; Ohmori K; Oshita A; Takeuchi H; Fuke S; Shinomiya K; Noma T; Namba T; Kohno M
J Am Coll Cardiol; 2004 Aug; 44(3):644-53. PubMed ID: 15358035
[TBL] [Abstract][Full Text] [Related]
18. Long-term pharmacological activation of PPARgamma does not prevent left ventricular remodeling in dogs with advanced heart failure.
Suzuki G; Khanal S; Rastogi S; Morita H; Mishima T; Anagnostopoulos PV; Nass O; Sharov VG; Tanhehco EJ; Goldstein S; Sabbah HN
Cardiovasc Drugs Ther; 2007 Feb; 21(1):29-36. PubMed ID: 17294127
[TBL] [Abstract][Full Text] [Related]
19. Effects of chronic neutral endopeptidase inhibition on the progression of left ventricular dysfunction and remodeling in dogs with moderate heart failure.
Mishima T; Tanimura M; Suzuki G; Todor A; Sharov VG; Tanhehco EJ; Goldstein S; Sabbah HN
Cardiovasc Drugs Ther; 2002 May; 16(3):209-14. PubMed ID: 12374898
[TBL] [Abstract][Full Text] [Related]
20. Vagus nerve stimulation improves left ventricular function in a canine model of chronic heart failure.
Hamann JJ; Ruble SB; Stolen C; Wang M; Gupta RC; Rastogi S; Sabbah HN
Eur J Heart Fail; 2013 Dec; 15(12):1319-26. PubMed ID: 23883651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
